A pilot clinical trial of a self-management intervention in patients with a left ventricular assist device
Autor: | Heidi Craddock, Marykay A. Pavol, Chakra Budhathoki, Danyelle Hoff, Millie Tiburcio, Gregory A. Ewald, Jesus M. Casida, Sarah E. Schroeder |
---|---|
Rok vydání: | 2021 |
Předmět: |
Nephrology
medicine.medical_specialty education.field_of_study Self-management business.industry medicine.medical_treatment Population Biomedical Engineering Medicine (miscellaneous) law.invention Cardiac surgery Biomaterials Clinical trial Randomized controlled trial law Ventricular assist device Internal medicine Intervention (counseling) medicine Physical therapy Cardiology and Cardiovascular Medicine education business |
Zdroj: | Journal of Artificial Organs. 25:91-104 |
ISSN: | 1619-0904 1434-7229 |
DOI: | 10.1007/s10047-021-01289-x |
Popis: | Self-management is a health behavior known to predict treatment outcomes in patients with multiple co-morbidities and/or chronic conditions. However, the self-management process and outcomes in the left-ventricular assist device (LVAD) population are understudied. This pilot randomized control trial (RCT) evaluated the feasibility of a novel “smartphone app-directed and nurse-supported self-management intervention” in patients implanted with durable LVADs. Assessments included behavioral (self-efficacy and adherence), clinical (complications), and healthcare utilization (unplanned clinic, emergency room (ER) visits, and re-hospitalization) outcomes, completed at baseline (pre-hospital discharge) and months 1, 3, and 6 post-hospital discharge. Intervention patients (n = 14) had favorable patterns/trends of results across study outcomes than control patients (n = 16). Notably, intervention patients had much lower complications and healthcare utilization rates than controls. For example, intervention patients had 2 (14.3%) driveline infections in 6 months while control patients had 3 (19.0%). Additionally, at month 3, intervention patients had 0% ER visits versus 36% of control patients. At month 6, the mean cumulative number of re-hospitalizations for the control group was higher (0.9 ± 0.93) than intervention (0.3 ± 0.61) group. Despite the small sample size and limitations of feasibility/pilot studies, our outcomes data appeared to favor the novel intervention. Lessons learned from this study suggest the intervention should be implemented for 6 months post-hospital discharge. Further research is needed including large and rigorous multi-center RCTs to generate knowledge explaining the mechanism of the effect of self-management on LVAD treatment outcomes. |
Databáze: | OpenAIRE |
Externí odkaz: |